ORI Capital
Venture capitalHong Kong · Pre-Seed–Late Stage · 15 people tracked
Investment thesis
ORI Capital backs innovative early-stage biotech companies on a global basis. Its funds focus on diagnostics, drug delivery, and therapeutics, targeting the disease areas responsible for the highest mortality rates, including cancer, cardiovascular disease, and neurodegenerative disease. The firm combines scientific insight with a mission to develop treatments that save lives, drawing on a mix of artificial and human intelligence in its investment approach.
Source: firm website, verified Aug 3, 2026.
Team · 15 people
from the firm's website & public directories
Investments · 2 tracked
founders shown can be your intro pathOnly company applying stem cell therapy to cure type 1 diabetes.
Boston-based biotech developing iPS-derived pancreatic islet therapies to cure insulin-dependent diabetes.
Frequently asked questions
- What stage does ORI Capital invest at?
- ORI Capital invests at the Pre-Seed, Seed, Series A, Series B, Late Stage stages.
- What sectors does ORI Capital focus on?
- ORI Capital focuses on AI & Machine Learning, Biotech, Healthtech, Impact & Social Good, Medical Devices.
- Where is ORI Capital located?
- ORI Capital is headquartered in Hong Kong, HK.
Similar investors
Artesian is a full-stack venture capital firm that leverages extensive regional and global networks to source and invest in early- and growth-stage startups across its key sectors.
LIFTT is a venture capital holding company focused on deep tech technologies, using an operational, multi-vertical approach aimed at generating impact. It works to transform scientific research into high-impact companies, accelerating the path from lab to market.
MaRS is a Toronto-based innovation hub and accelerator that supports Canadian startups from pre-seed funding through international expansion, offering workspace, mentorship, investor and customer connections, and sector-focused programming.
Muirwoods Ventures is a venture capital firm investing in healthcare, technology, mobility, and the environment, with an emphasis on sustainability and mass-market solutions.